Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Asian J Surg. 2019 Dec;42(12):981-989. doi: 10.1016/j.asjsur.2019.01.009. Epub 2019 Feb 16.
Portal hypertension (PH), which is closely associated with the severity of liver cirrhosis, has been suggested as a contraindication of liver resection for hepatocellular carcinoma (HCC). We aimed to explore the role of a potential player, histologic severity of liver cirrhosis, in affecting surgical outcomes of the patients with both HCC and PH.
A total of 374 HCC patients with PH underwent resection for HCC were retrospectively reviewed. By using the Laennec staging system, the patients were divided into two groups: the mild-moderate cirrhosis (MMC) group and the severe cirrhosis (SC) group. Propensity score matching (PSM) was conducted at a 1:1 ratio between the two groups, and 89 patients were matched for each group. Short-term and long-term outcomes were compared between two groups before and after PSM.
The overall morbidity and 30-days mortality were significantly higher in the SC group than the MCC group (52.9% vs. 30.1%, P < 0.001 and 6.9% vs. 0.7%, P = 0.002). Severe cirrhosis was identified as an independent predictor of postoperative liver-related complications. Patients with MMC exhibited better 5-year overall survival (39.9% vs. 16.9%, P < 0.001) and disease-free survival (10.5% vs. 4.4%, P < 0.001) than those with SC. Multivariate analysis indicated that severe cirrhosis was significantly associated with lower disease-free survival and overall survival. These results were further confirmed in the PSM cohort.
Histologic severity of liver cirrhosis determines the surgical outcomes of patients with both HCC and PH, and PH is not an absolute contraindication of liver resection.
门静脉高压症(PH)与肝硬化的严重程度密切相关,被认为是肝癌(HCC)患者行肝切除术的禁忌证。本研究旨在探讨肝脏组织学严重程度在影响合并 PH 的 HCC 患者手术结果中的作用。
回顾性分析了 374 例 PH 合并 HCC 患者接受 HCC 切除术的临床资料。采用 Laennec 分期系统,将患者分为两组:轻度至中度肝硬化(MMC)组和重度肝硬化(SC)组。采用倾向评分匹配(PSM)以 1:1 的比例对两组进行匹配,每组匹配 89 例。比较 PSM 前后两组患者的短期和长期预后。
SC 组的总并发症发生率和 30 天死亡率明显高于 MMC 组(52.9%比 30.1%,P<0.001;6.9%比 0.7%,P=0.002)。重度肝硬化是术后肝相关并发症的独立预测因素。MMC 组患者的 5 年总生存率(39.9%比 16.9%,P<0.001)和无病生存率(10.5%比 4.4%,P<0.001)均优于 SC 组。多因素分析表明,重度肝硬化与无病生存率和总生存率显著降低相关。这些结果在 PSM 队列中得到进一步证实。
肝脏组织学严重程度决定了合并 PH 的 HCC 患者的手术结果,PH 不是肝切除术的绝对禁忌证。